We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Non-Opioid Pain Treatment industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Medical Cannabis Treatment
Capsaicin-derived Treatment
Menthol-containing Treatment
Omega 3 fatty acid-containing Treatment
Botulinum Toxins
Market Segment by Product Application
Orthopaedic and Musculoskeletal Pain
Neuropathic Pain
Cancer Pain
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Allergan PLC
Canopy Growth
Medical Marijuana Inc.
Panag Pharma Inc.
Tilray
Aphria Inc.
Bedrocan
Cara Therapeutics
Centrexion Therapeutics
CHT Medical
Cronos Group
GW Pharmaceuticals
Medropharm Gmbh
US Worldmeds LLC
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Non-Opioid Pain Treatment consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Non-Opioid Pain Treatment market by identifying its various subsegments.
3.Focuses on the key global Non-Opioid Pain Treatment manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Non-Opioid Pain Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Non-Opioid Pain Treatment submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Non-Opioid Pain Treatment Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Non-Opioid Pain Treatment Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Non-Opioid Pain Treatment Segment by Type
2.1.1 Medical Cannabis Treatment
2.1.2 Capsaicin-derived Treatment
2.1.3 Menthol-containing Treatment
2.1.4 Omega 3 fatty acid-containing Treatment
2.1.5 Botulinum Toxins
2.2 Market Analysis by Application
2.2.1 Orthopaedic and Musculoskeletal Pain
2.2.2 Neuropathic Pain
2.2.3 Cancer Pain
2.2.4 Others
2.3 Global Non-Opioid Pain Treatment Market Comparison by Regions (2017-2027)
2.3.1 Global Non-Opioid Pain Treatment Market Size (2017-2027)
2.3.2 North America Non-Opioid Pain Treatment Status and Prospect (2017-2027)
2.3.3 Europe Non-Opioid Pain Treatment Status and Prospect (2017-2027)
2.3.4 China Non-Opioid Pain Treatment Status and Prospect (2017-2027)
2.3.5 Japan Non-Opioid Pain Treatment Status and Prospect (2017-2027)
2.3.6 Southeast Asia Non-Opioid Pain Treatment Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Non-Opioid Pain Treatment Industry Impact
2.5.1 Non-Opioid Pain Treatment Business Impact Assessment - Covid-19
2.5.2 Market Trends and Non-Opioid Pain Treatment Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Non-Opioid Pain Treatment Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Non-Opioid Pain Treatment Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Non-Opioid Pain Treatment Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Non-Opioid Pain Treatment Manufacturer Market Share
3.5 Top 10 Non-Opioid Pain Treatment Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Non-Opioid Pain Treatment Market
3.7 Key Manufacturers Non-Opioid Pain Treatment Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Non-Opioid Pain Treatment Industry Key Manufacturers
4.1 Allergan PLC
4.1.1 Compan Detail
4.1.2 Allergan PLC Non-Opioid Pain Treatment Product Introduction, Application and Specification
4.1.3 Allergan PLC 167 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Allergan PLC News
4.2 Canopy Growth
4.2.1 Compan Detail
4.2.2 Canopy Growth Non-Opioid Pain Treatment Product Introduction, Application and Specification
4.2.3 Canopy Growth Non-Opioid Pain Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Allergan PLC News
4.3 Medical Marijuana Inc.
4.3.1 Compan Detail
4.3.2 Medical Marijuana Inc. Non-Opioid Pain Treatment Product Introduction, Application and Specification
4.3.3 Medical Marijuana Inc. Non-Opioid Pain Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Medical Marijuana Inc. News
4.4 Panag Pharma Inc.
4.4.1 Compan Detail
4.4.2 Panag Pharma Inc. Non-Opioid Pain Treatment Product Introduction, Application and Specification
4.4.3 Panag Pharma Inc. Non-Opioid Pain Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Panag Pharma Inc. News
4.5 Tilray
4.5.1 Compan Detail
4.5.2 Panag Pharma Inc. Non-Opioid Pain Treatment Product Introduction, Application and Specification
4.5.3 Tilray Non-Opioid Pain Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Tilray News
4.6 Aphria Inc.
4.6.1 Compan Detail
4.6.2 Aphria Inc. Non-Opioid Pain Treatment Product Introduction, Application and Specification
4.6.3 Aphria Inc. Non-Opioid Pain Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Aphria Inc. News
4.7 Bedrocan
4.7.1 Compan Detail
4.7.2 Bedrocan Non-Opioid Pain Treatment Product Introduction, Application and Specification
4.7.3 Bedrocan Non-Opioid Pain Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Cara Therapeutics
4.8.1 Compan Detail
4.8.2 Cara Therapeutics Non-Opioid Pain Treatment Product Introduction, Application and Specification
4.8.3 Cara Therapeutics Non-Opioid Pain Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Cara Therapeutics News
4.9 Centrexion Therapeutics
4.9.1 Compan Detail
4.9.2 Centrexion Therapeutics Non-Opioid Pain Treatment Product Introduction, Application and Specification
4.9.3 Centrexion Therapeutics Non-Opioid Pain Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Centrexion Therapeutics News
4.10 CHT Medical
4.10.1 Compan Detail
4.10.2 CHT Medical Non-Opioid Pain Treatment Product Introduction, Application and Specification
4.10.3 CHT Medical Non-Opioid Pain Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 CHT Medical News
4.11 Cronos Group
4.11.1 Compan Detail
4.11.2 Cronos Group Non-Opioid Pain Treatment Product Introduction, Application and Specification
4.11.3 Cronos Group Non-Opioid Pain Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Cronos Group News
4.12 GW Pharmaceuticals
4.12.1 Compan Detail
4.12.2 GW Pharmaceuticals Non-Opioid Pain Treatment Product Introduction, Application and Specification
4.12.3 GW Pharmaceuticals Non-Opioid Pain Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 GW Pharmaceuticals News
4.13 Medropharm Gmbh
4.13.1 Company Details
4.13.2 Medropharm Gmbh Non-Opioid Pain Treatment Product Introduction, Application and Specification
4.13.3 Medropharm Gmbh Non-Opioid Pain Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Medropharm Gmbh News
4.14 US Worldmeds LLC
4.14.1 Compan Detail
4.14.2 US Worldmeds LLC Non-Opioid Pain Treatment Product Introduction, Application and Specification
4.14.3 US Worldmeds LLC Non-Opioid Pain Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 US Worldmeds LLC News
5 Global Non-Opioid Pain Treatment Market Segment by Big Type
5.1 Global Non-Opioid Pain Treatment Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Non-Opioid Pain Treatment Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Non-Opioid Pain Treatment Revenue and Market Share by Big Type (2017-2022)
5.2 Medical Cannabis Treatment Sales Growth Rate and Price
5.2.1 Global Medical Cannabis Treatment Sales Growth Rate (2017-2022)
5.2.2 Global Medical Cannabis Treatment Price (2017-2022)
5.3 Capsaicin-derived Treatment Sales Growth Rate and Price
5.3.1 Global Capsaicin-derived Treatment Sales Growth Rate (2017-2022)
5.3.2 Global Capsaicin-derived Treatment Price (2017-2022)
5.4 Menthol-containing Treatment Sales Growth Rate and Price
5.4.1 Global Menthol-containing Treatment Sales Growth Rate (2017-2022)
5.4.2 Global Menthol-containing Treatment Price (2017-2022)
5.5 Omega 3 fatty acid-containing Treatment Sales Growth Rate and Price
5.5.1 Global Omega 3 fatty acid-containing Treatment Sales Growth Rate (2017-2022)
5.5.2 Global Omega 3 fatty acid-containing Treatment Price (2017-2022)
5.6 Botulinum Toxins Sales Growth Rate and Price
5.6.1 Global Botulinum Toxins Sales Growth Rate (2017-2022)
5.6.2 Global Botulinum Toxins Price (2017-2022)
6 Global Non-Opioid Pain Treatment Market Segment by Big Application
6.1 Global Non-Opioid Pain Treatment Sales Market Share by Big Application (2017-2022)
6.2 Orthopaedic and Musculoskeletal Pain Sales Growth Rate (2017-2022)
6.3 Neuropathic Pain Sales Growth Rate (2017-2022)
6.4 Cancer Pain Sales Growth Rate (2017-2022)
6.5 Others Sales Growth Rate (2017-2022)
7 Global Non-Opioid Pain Treatment Forecast
7.1 Global Non-Opioid Pain Treatment Revenue, Sales and Growth Rate (2022-2027)
7.2 Non-Opioid Pain Treatment Market Forecast by Regions (2022-2027)
7.2.1 North America Non-Opioid Pain Treatment Market Forecast (2022-2027)
7.2.2 Europe Non-Opioid Pain Treatment Market Forecast (2022-2027)
7.2.3 China Non-Opioid Pain Treatment Market Forecast (2022-2027)
7.2.4 Japan Non-Opioid Pain Treatment Market Forecast (2022-2027)
7.2.5 Southeast Asia Non-Opioid Pain Treatment Market Forecast (2022-2027)
7.2.6 Other Regions Non-Opioid Pain Treatment Market Forecast (2022-2027)
7.3 Non-Opioid Pain Treatment Market Forecast by Type (2022-2027)
7.3.1 Global Non-Opioid Pain Treatment Sales Forecast by Type (2022-2027)
7.3.2 Global Non-Opioid Pain Treatment Market Share Forecast by Type (2022-2027)
7.4 Non-Opioid Pain Treatment Market Forecast by Application (2022-2027)
7.4.1 Global Non-Opioid Pain Treatment Sales Forecast by Application (2022-2027)
7.4.2 Global Non-Opioid Pain Treatment Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Non-Opioid Pain Treatment Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Non-Opioid Pain Treatment Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Non-Opioid Pain Treatment
Figure Market Concentration Ratio and Market Maturity Analysis of Non-Opioid Pain Treatment
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Non-Opioid Pain Treatment Market Size by Big Type
Figure Global Market Share of Non-Opioid Pain Treatment by Big Type in 2021
Figure Medical Cannabis Treatment Picture (2017-2022)
Figure Capsaicin-derived Treatment Picture (2017-2022)
Figure Menthol-containing Treatment Picture (2017-2022)
Figure Omega 3 fatty acid-containing Treatment Picture (2017-2022)
Global Non-Opioid Pain Treatment Market Size by Big Application
Table Global Non-Opioid Pain Treatment Market Size by Application
Figure Global Non-Opioid Pain Treatment Market Share by Big Application in 2021
Figure Orthopaedic and Musculoskeletal Pain Picture
Figure Neuropathic Pain Picture
Figure Cancer Pain Picture
Figure Others Picture
Table Global Non-Opioid Pain Treatment Comparison by Regions (M USD) (2017-2027)
Figure Global Non-Opioid Pain Treatment Market Size (Million US$) (2017-2027)
Figure North America Non-Opioid Pain Treatment Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Non-Opioid Pain Treatment Revenue (Million US$) Growth Rate (2017-2027)
Figure China Non-Opioid Pain Treatment Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Non-Opioid Pain Treatment Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Non-Opioid Pain Treatment Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Non-Opioid Pain Treatment Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Non-Opioid Pain Treatment Sales by Manufacturer (2017-2022)
Figure Global Non-Opioid Pain Treatment Sales Market Share by Manufacturer in 2021
Table Global Non-Opioid Pain Treatment Revenue by Manufacturer (2017-2022)
Figure Global Non-Opioid Pain Treatment Revenue Market Share by Manufacturer in 2021
Table Global Non-Opioid Pain Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Non-Opioid Pain Treatment Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Non-Opioid Pain Treatment Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Non-Opioid Pain Treatment Market
Table Key Manufacturers Non-Opioid Pain Treatment Product Type
Table Mergers & Acquisitions Planning
Table Allergan PLC Company Profile
Table Non-Opioid Pain Treatment Product Introduction, Application and Specification of Allergan PLC
Table Non-Opioid Pain Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Canopy Growth Company Profile
Table Non-Opioid Pain Treatment Product Introduction, Application and Specification of Canopy Growth
Table Non-Opioid Pain Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Canopy Growth Recent Development
Table Medical Marijuana Inc. Company Profile
Table Non-Opioid Pain Treatment Product Introduction, Application and Specification of Medical Marijuana Inc.
Table Non-Opioid Pain Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Medical Marijuana Inc. Main Business
Table Medical Marijuana Inc. Recent Development
Table Panag Pharma Inc. Company Profile
Table Non-Opioid Pain Treatment Product Introduction, Application and Specification of Panag Pharma Inc.
Table Non-Opioid Pain Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Panag Pharma Inc. Main Business
Table Panag Pharma Inc. Recent Development
Table Panag Pharma Inc. Main Business
Table Panag Pharma Inc. Recent Development
Table Tilray Company Profile
Table Non-Opioid Pain Treatment Product Introduction, Application and Specification of Tilray
Table Non-Opioid Pain Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Tilray Main Business
Table Tilray Recent Development
Table Aphria Inc. Company Profile
Table Non-Opioid Pain Treatment Product Introduction, Application and Specification of Aphria Inc.
Table Non-Opioid Pain Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Aphria Inc. Main Business
Table Aphria Inc. Recent Development
Table Bedrocan Company Profile
Table Non-Opioid Pain Treatment Product Introduction, Application and Specification of Bedrocan
Table Non-Opioid Pain Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bedrocan Main Business
Table Bedrocan Recent Development
Table Cara Therapeutics Company Profile
Table Non-Opioid Pain Treatment Product Introduction, Application and Specification of Cara Therapeutics
Table Non-Opioid Pain Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cara Therapeutics Main Business
Table Cara Therapeutics Recent Development
Table Centrexion Therapeutics Company Profile
Table Non-Opioid Pain Treatment Product Introduction, Application and Specification of Centrexion Therapeutics
Table Non-Opioid Pain Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Centrexion Therapeutics Main Business
Table Centrexion Therapeutics Recent Development
Table CHT Medical Company Profile
Table Non-Opioid Pain Treatment Product Introduction, Application and Specification of CHT Medical
Table Non-Opioid Pain Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table CHT Medical Main Business
Table CHT Medical Recent Development
Table Cronos Group Company Profile
Table Non-Opioid Pain Treatment Product Introduction, Application and Specification of Cronos Group
Table Non-Opioid Pain Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cronos Group Main Business
Table Cronos Group Recent Development
Table GW Pharmaceuticals Company Profile
Table Non-Opioid Pain Treatment Product Introduction, Application and Specification of GW Pharmaceuticals
Table Non-Opioid Pain Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GW Pharmaceuticals Main Business
Table GW Pharmaceuticals Recent Development
Table Medropharm Gmbh Company Profile
Table Non-Opioid Pain Treatment Product Introduction, Application and Specification of Medropharm Gmbh
Table Non-Opioid Pain Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Medropharm Gmbh Main Business
Table Medropharm Gmbh Recent Development
Table US Worldmeds LLC Company Profile
Table Non-Opioid Pain Treatment Product Introduction, Application and Specification of US Worldmeds LLC
Table Non-Opioid Pain Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table US Worldmeds LLC Main Business
Table US Worldmeds LLC Recent Development
Figure Global Non-Opioid Pain Treatment Sales and Growth Rate (2017-2022)
Figure Global Non-Opioid Pain Treatment Revenue and Growth Rate (2017-2022)
Table Global Non-Opioid Pain Treatment Sales by Regions (2017-2022)
Figure Global Non-Opioid Pain Treatment Sales Market Share by Regions in 2021
Table Global Non-Opioid Pain Treatment Revenue by Regions (2017-2022)
Figure Global Non-Opioid Pain Treatment Revenue Market Share by Regions in 2021
Figure North America Non-Opioid Pain Treatment Sales and Growth Rate (2017-2022)
Figure Europe Non-Opioid Pain Treatment Sales and Growth Rate (2017-2022)
Figure China Non-Opioid Pain Treatment Sales and Growth Rate (2017-2022)
Figure Japan Non-Opioid Pain Treatment Sales and Growth Rate (2017-2022)
Figure Southeast Asia Non-Opioid Pain Treatment Sales and Growth Rate (2017-2022)
Figure Other Regions Non-Opioid Pain Treatment Sales and Growth Rate (2017-2022)
Table Global Non-Opioid Pain Treatment Sales by Big Type (2017-2022)
Table Global Non-Opioid Pain Treatment Sales Market Share by Big Type (2017-2022)
Figure Global Non-Opioid Pain Treatment Sales Market Share by Big Type in 2019
Table Global Non-Opioid Pain Treatment Revenue by Big Type (2017-2022)
Table Global Non-Opioid Pain Treatment Revenue Market Share by Big Type (2017-2022)
Table Global Non-Opioid Pain Treatment Revenue Market Share by Big Type in 2019
Figure Global Medical Cannabis Treatment Sales Growth Rate (2017-2022)
Figure Global Medical Cannabis Treatment Price (2017-2022)
Figure Global Capsaicin-derived Treatment Sales Growth Rate (2017-2022)
Figure Global Capsaicin-derived Treatment Price (2017-2022)
Figure Global Menthol-containing Treatment Sales Growth Rate (2017-2022)
Figure Global Menthol-containing Treatment Price (2017-2022)
Figure Global Omega 3 fatty acid-containing Treatment Sales Growth Rate (2017-2022)
Figure Global Omega 3 fatty acid-containing Treatment Price (2017-2022)
Table Global Non-Opioid Pain Treatment Sales by Big Application (2017-2022)
Table Global Non-Opioid Pain Treatment Sales Market Share by Big Application (2017-2022)
Figure Global Non-Opioid Pain Treatment Sales Market Share by Big Application in 2019
Figure Global Orthopaedic and Musculoskeletal Pain Sales Growth Rate (2017-2022)
Figure Global Neuropathic Pain Sales Growth Rate (2017-2022)
Figure Global Cancer Pain Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Non-Opioid Pain Treatment Sales and Growth Rate (2022-2027)
Figure Global Non-Opioid Pain Treatment Revenue and Growth Rate (2022-2027)
Table Global Non-Opioid Pain Treatment Sales Forecast by Regions (2022-2027)
Table Global Non-Opioid Pain Treatment Market Share Forecast by Regions (2022-2027)
Figure North America Sales Non-Opioid Pain Treatment Market Forecast (2022-2027)
Figure Europe Sales Non-Opioid Pain Treatment Market Forecast (2022-2027)
Figure China Sales Non-Opioid Pain Treatment Market Forecast (2022-2027)
Figure Japan Sales Non-Opioid Pain Treatment Market Forecast (2022-2027)
Figure Southeast Asia Sales Non-Opioid Pain Treatment Market Forecast (2022-2027)
Figure Other Regions Sales Non-Opioid Pain Treatment Market Forecast (2022-2027)
Table Global Non-Opioid Pain Treatment Sales Forecast by Type (2022-2027)
Table Global Non-Opioid Pain Treatment Market Share Forecast by Type (2022-2027)
Table Global Non-Opioid Pain Treatment Sales Forecast by Application (2022-2027)
Table Global Non-Opioid Pain Treatment Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-Opioid Pain Treatment
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Non-Opioid Pain Treatment Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Non-Opioid Pain Treatment Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Non-Opioid Pain Treatment Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Non-Opioid Pain Treatment Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Non-Opioid Pain Treatment Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Non-Opioid Pain Treatment Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Non-Opioid Pain Treatment Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Non-Opioid Pain Treatment Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Allergan PLC
Canopy Growth
Medical Marijuana Inc.
Panag Pharma Inc.
Tilray
Aphria Inc.
Bedrocan
Cara Therapeutics
Centrexion Therapeutics
CHT Medical
Cronos Group
GW Pharmaceuticals
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)